The GvHD Hub release new ECP resource
The UKPS were delighted to work with the GvHD Hub, to produce a new recourse for ECP education.
The GvHD Hub spoke to Profressor Andrew Gennery, Newcastle University and Great North Children’s Hospital, Newcastle upon Tyne, UK, and Chair of the UK Photopheresis Society, about the future directions of extracorporeal photopheresis (ECP) for the treatment of GvHD.
In this interview, Professor Gennery begins by providing a background to using ECP in pediatric patients, including the potential complications involved and how to mitigate these. He then discusses the process of ECP, including mechanism of action, treatment scheduling, and its efficacy in different types of GvHD.
Professor Gennery goes on to speak about how the treatment landscape for GvHD has changed in the last 5 years, how it might change in the future, and where ECP fits in as an immunomodulatory agent. In the future, ECP may be combined with the newer immunosuppressive agents that are approved, or in development, for the treatment of GvHD to deliver positive outcomes for patients.
You can access the full interview here.
The UK Photopheresis Society 